Search Results

There are 5383 results for: content related to: Association between amantadine and the onset of dementia in Parkinson's disease

  1. You have free access to this content
    Amantadine and rimantadine for influenza A in adults

    Intervention Review

    The Cochrane Library

    Tom Jefferson, Vittorio Demicheli, Carlo Di Pietrantonj and Daniela Rivetti

    Published Online : 19 APR 2006, DOI: 10.1002/14651858.CD001169.pub3

  2. Amantadine in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Niall J Crosby, Katherine Deane and Carl E Clarke

    Published Online : 20 JAN 2003, DOI: 10.1002/14651858.CD003468

  3. Amantadine in treatment of chronic hepatitis C virus infection?

    Journal of Viral Hepatitis

    Volume 12, Issue 5, September 2005, Pages: 445–455, J. K. Lim, D. Wooten, R. Siegel and R. C. Cheung

    Article first published online : 9 JUN 2005, DOI: 10.1111/j.1365-2893.2005.00622.x

  4. Amantadine and equine influenza: pharmacology, pharmacokinetics and neurological effects in the horse

    Equine Veterinary Journal

    Volume 29, Issue 2, March 1997, Pages: 104–110, W. A. REES, J. D. HARKINS, W. E. WOODS, R. A. BLOWN, M. LU, CLARA FENGER, R. E. HOLLAND, T. M. CHAMBERS and T. TOBIN

    Article first published online : 23 APR 2010, DOI: 10.1111/j.2042-3306.1997.tb01650.x

  5. Effect of amantadine on oxymorphone-induced thermal antinociception in cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 35, Issue 2, April 2012, Pages: 169–174, K. T. SIAO, B. H. PYPENDOP, A. ESCOBAR, S. D. STANLEY and J. E. ILKIW

    Article first published online : 28 APR 2011, DOI: 10.1111/j.1365-2885.2011.01305.x

  6. Involvement of the sigma1 receptor in the modulation of dopaminergic transmission by amantadine

    European Journal of Neuroscience

    Volume 19, Issue 8, April 2004, Pages: 2212–2220, Magali Peeters, Pascal Romieu, Tangui Maurice, Tsung-Ping Su, Jean-Marie Maloteaux and Emmanuel Hermans

    Article first published online : 16 APR 2004, DOI: 10.1111/j.0953-816X.2004.03297.x

  7. You have full text access to this OnlineOpen article
    Amantadine Therapy for Chronic Hepatitis C

    Journal of General Internal Medicine

    Volume 19, Issue 6, June 2004, Pages: 662–668, Jill P. Smith, Thomas R. Riley III, Attila Devenyi, Sandra I. Bingaman and Allen Kunselman

    Article first published online : 9 JUN 2004, DOI: 10.1111/j.1525-1497.2004.30057.x

  8. Beneficial Effect of Amantadine on Postoperative Pain Reduction and Consumption of Morphine in Patients Subjected to Elective Spine Surgery

    Pain Medicine

    Volume 13, Issue 3, March 2012, Pages: 459–465, Beata Bujak-Giżycka, Katarzyna Kącka, Maciej Suski, Rafał Olszanecki, Józef Madej, Jan Dobrogowski and Ryszard Korbut

    Article first published online : 7 FEB 2012, DOI: 10.1111/j.1526-4637.2011.01321.x

  9. You have full text access to this OnlineOpen article
    Amantadine inhibits RANTES production by influenzavirus-infected human bronchial epithelial cells

    British Journal of Pharmacology

    Volume 132, Issue 4, February 2001, Pages: 918–924, Yasukiyo Asai, Shu Hashimoto, Kousei Kujime, Yasuhiro Gon, Kenji Mizumura, Kazufumi Shimizu and Takashi Horie

    Article first published online : 29 JAN 2009, DOI: 10.1038/sj.bjp.0703870

  10. Anti-dyskinetic mechanisms of amantadine and dextromethorphan in the 6-OHDA rat model of Parkinson’s disease: role of NMDA vs. 5-HT1A receptors

    European Journal of Neuroscience

    Volume 36, Issue 9, November 2012, Pages: 3224–3234, Melanie A. Paquette, Alex A. Martinez, Teresa Macheda, Charles K. Meshul, Steven W. Johnson, S. Paul Berger and Andrea Giuffrida

    Article first published online : 3 AUG 2012, DOI: 10.1111/j.1460-9568.2012.08243.x

  11. Amantadine for fatigue in multiple sclerosis

    Intervention Review

    The Cochrane Library

    Eugenio Pucci, Pedro Brañas Tato, Roberto D'Amico, Giorgio Giuliani, Alessandra Solari and Cristiana Taus

    Published Online : 24 JAN 2007, DOI: 10.1002/14651858.CD002818.pub2

  12. Amantadine for dyskinesia in Parkinson's disease

    Intervention Review

    The Cochrane Library

    Niall J Crosby, Katherine Deane and Carl E Clarke

    Published Online : 22 APR 2003, DOI: 10.1002/14651858.CD003467

  13. A novel method of resistance for influenza against a channel-blocking antiviral drug

    Proteins: Structure, Function, and Bioinformatics

    Volume 55, Issue 2, 1 May 2004, Pages: 251–257, Peleg Astrahan, Itamar Kass, Matthew A. Cooper and Isaiah T. Arkin

    Article first published online : 18 MAR 2004, DOI: 10.1002/prot.20018

  14. You have full text access to this OnlineOpen article
    Placebo-controlled trial of 400 mg amantadine combined with peginterferon alfa-2a and ribavirin for 48 weeks in chronic hepatitis C virus-1 infection

    Hepatology

    Volume 48, Issue 5, November 2008, Pages: 1404–1411, Michael von Wagner, Wolf Peter Hofmann, Gerlinde Teuber, Thomas Berg, Tobias Goeser, Ulrich Spengler, Holger Hinrichsen, Hans Weidenbach, Guido Gerken, Michael Manns, Peter Buggisch, Eva Herrmann and Stefan Zeuzem

    Article first published online : 19 JUN 2008, DOI: 10.1002/hep.22483

  15. Pharmacokinetics of amantadine in cats

    Journal of Veterinary Pharmacology and Therapeutics

    Volume 34, Issue 6, December 2011, Pages: 599–604, K. T. SIAO, B. H. PYPENDOP, S. D. STANLEY and J. E. ILKIW

    Article first published online : 16 FEB 2011, DOI: 10.1111/j.1365-2885.2011.01278.x

  16. Rimantadine in Parkinson's disease patients experiencing peripheral adverse effects from amantadine: Report of a case series

    Movement Disorders

    Volume 20, Issue 7, July 2005, Pages: 873–877, Carlos Singer, Spiridon Papapetropoulos, Manuel A. Gonzalez, Eugene L. Roberts and Abraham Lieberman

    Article first published online : 4 APR 2005, DOI: 10.1002/mds.20471

  17. You have full text access to this OnlineOpen article
    A randomized controlled trial of amantadine plus interferon-α2a vs. interferon-α2a alone in naive patients with chronic hepatitis C randomized according to the early virological response to interferon-α2a monotherapy

    Alimentary Pharmacology & Therapeutics

    Volume 19, Issue 3, February 2004, Pages: 339–347, M. Angelico, , M. Cepparulo, F. Angelico, S. Francioso, A. Barlattani, F. Di Candilo, R. Della Vecchia, L. Demelia, G. De Sanctis, S. Gentile, A. Grieco, G. Parruti, G. Sabusco, L. Tarquini, A. Tosti, S. Zaru and THE SMIEC 1 GROUP

    Article first published online : 20 JAN 2004, DOI: 10.1111/j.1365-2036.2004.01843.x

  18. Emergence and Transmission of Amantadine-Resistant Influenza A in a Nursing Home

    Journal of the American Geriatrics Society

    Volume 52, Issue 12, December 2004, Pages: 2069–2073, Margo Schilling, Stefan Gravenstein, Paul Drinka, Nancy Cox, Peggy Krause, Laura Povinelli and Peter Shult

    Article first published online : 18 NOV 2004, DOI: 10.1111/j.1532-5415.2004.52567.x

  19. Economic Evaluation of Oseltamivir Phosphate for Postexposure Prophylaxis of Influenza in Long-Term Care Facilities

    Journal of the American Geriatrics Society

    Volume 53, Issue 3, March 2005, Pages: 444–451, Nancy A. Risebrough, Susan K. Bowles, Andrew E. Simor, Alison McGeer and Paul I. Oh

    Article first published online : 24 FEB 2005, DOI: 10.1111/j.1532-5415.2005.53162.x

  20. Simultaneous determination of memantine and amantadine in human plasma as fluorescein derivatives by micellar electrokinetic chromatography with laser-induced fluorescence detection and its clinical application

    ELECTROPHORESIS

    Volume 31, Issue 11, June 2010, Pages: 1903–1911, Hsin-Hua Yeh, Yuan-Han Yang and Su-Hwei Chen

    Article first published online : 5 MAY 2010, DOI: 10.1002/elps.201000001